Sign in
4

Changes in Ownership

Cartesian Therapeutics, Inc. Filed Acc 0001638599-17-000662

Director bought 338,791 shares at $17.71 ($5,999,989)

From the SEC's structured data for this filing

Trades in this filing

SPRINGER TIMOTHY A · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2017-06-27 Purchase : show line 1 in the form +338,791 $17.71 $5,999,989 355,413 D
Open-market purchases · 338,791 sh · avg $17.71 · $5,999,989

Table II: Derivative

1 line
Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
2017-06-27 Purchase : show line 2 in the form Warrant (right to buy) +79,130 $0.13 $9,891 $17.71 2022-06-27 79,130 79,130 D
Loading xslF345X03/doc4_4824.xml…